News

ALIPANC Online Seminar – Dr. Prof. Dieter – July 21, 3:00 p.m. CET

by | 1 de July de 2026 | Sin categorizar | 0 Comments

Speaker: Dr. Prof. Dieter Saur Institution: Technical University of Munich Title:“Decoding the PDAC Ecosystem Through Integrated Computational and Experimental Approaches” Description On July 21 at 3:00 p.m. CET, ALIPANC will hold another session of the ALIPANC...
Read more

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer

by | 26 de June de 2026 | Uncategorized | 0 Comments

Pancreatic cancer carries a dismal prognosis, with a median survival of less than six months following progression on standard chemotherapy. Precision oncology initiatives have historically benefited only a minority of patients, leaving systemic chemotherapy as the...
Read more

A new treatment strategy targets pancreatic cancer and boosts the immune system

by | 18 de June de 2026 | Sin categorizar | 0 Comments

A study led by the Hospital del Mar Research Institute and the IIBB-CSIC has identified a new strategy for treating pancreatic cancer based on inhibiting the PARP2 protein. The results, published in Science Advances, show in animal models that blocking this protein...
Read more

2nd Theoretical and Practical Refresher Course for Young Pancreatologists

by | 16 de June de 2026 | Sin categorizar | 0 Comments

September 25–26, 2026 Cruces University Hospital (Barakaldo) A course designed to provide an update on pancreatology, combining theoretical and practical training, and covering the diagnosis, characterization, and management of pancreatic lesions through sessions led...
Read more

ALIPANC Online Seminar – April 13th, 14:00h CET

by | 26 de March de 2026 | Sin categorizar | 0 Comments

Speaker: Prof. Andreas Trumpp Affiliation: German Cancer Research Center (DKFZ) & HI-STEM Title: "Profiling and targeting of innervating peripheral neurons in pancreatic cancer" (Profiling and targeting of peripheral neurons innervating pancreatic cancer)  ...
Read more

Folate- and aCD47-functionalized lipid nanoparticles efficiently deliver mRNA and remodel pancreatic tumor microenvironment.

by | 26 de March de 2026 | Sin categorizar | 0 Comments

ALIPANC researchers demonstrate that functionalization of lipid nanoparticles with "don't eat me signal" blocking antibodies, such as the CD47/SIRP axis α, result in a further increase of macrophage phagocytic activity on tumor cells. In addition, enrichment of...
Read more

3rd ALIPANC Scientific Meeting on Pancreatic Cancer

by | 19 de March de 2026 | Sin categorizar | 0 Comments

The 3rd Scientific Meeting of ALIPANC brings together more than 80 experts to promote translational research in pancreatic cancer. On March 13, the 3rd scientific meeting of ALIPANC took place at the HM Sanchinarro University Hospital in Madrid, with the attendance of...
Read more

Annual Scientific Meeting 2026

by | 3 de February de 2026 | Uncategorized | 0 Comments

March 13, 2026 Hospital Universitario HM Sanchinarro (Madrid). On-site event Scientific Coordination: Jorge Adeva Alfonso, Rafael Alvarez, Justo P. Castaño, Florian Castet, Elisa Espinet, Cristina Fillat, Carmen Guerra, Ismael Macías, Andres Muñoz, Francisco X. Real,...
Read more

CNIO Seminar: Dr. Florencia McAllister – “Cancer as an ecosystem: how microbes shape tumors”.

by | 23 de January de 2026 | Sin categorizar | 0 Comments

We are pleased to announce an upcoming seminar of special interest to the pancreatic cancer research community. On Friday, January 23, at 12:00 noon (CET), Dr. Florencia McAllister, M.D., Associate Professor of Clinical Cancer Prevention and Gastrointestinal Medical...
Read more

ALIPANC researchers conducted a study that links venous thromboembolic disease (VTE) with poorer survival in pancreatic cancer patients

by | 14 de January de 2026 | Sin categorizar | 0 Comments

The group led by Andrés Muñoz (Gregorio Marañón Hospital, Madrid) has published a subanalysis of the ONCOTHROMB12-01 study, which examines the impact of a diagnosis of venous thromboembolic disease (VTE) on the overall survival of cancer patients. A diagnosis of VTE...
Read more